Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörg Heineke

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Molecular and Cellular Cardiology|July 21, 2009
MLP: a stress sensor goes nuclearSylvia Gunkel, Jörg Heineke, Denise Hilfiker-Kleiner, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytesKai C Wollert, Beate Fiedler, Stepan Gambaryan, et al.
International Journal of Molecular Sciences|September 22, 2019
FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and FibrosisIneke Böckmann, Jonas Lischka, Beatrice Richter, et al.
Circulation|March 19, 2003
Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophyJörg Heineke, Tibor Kempf, Theresia Kraft, et al.
Cardiovascular Research|July 28, 2004
Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytesJörn Tongers, Beate Fiedler, Danny König, et al.
Circulation Research|January 7, 2006
The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injuryTibor Kempf, Matthias Eden, Jens Strelau, et al.
JCI Insight|May 19, 2017
Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progressionJames T Thackeray, Stefan Pietzsch, Britta Stapel, et al.
European Heart Journal|April 16, 2020
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human heartsLuka Nicin, Wesley Tyler Abplanalp, Hannah Mellentin, et al.
Circulation|January 26, 2011
Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarctionMortimer Korf-Klingebiel, Tibor Kempf, Klaus-Dieter Schlüter, et al.
Cardiovascular Research|June 3, 2011
Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodellingFrank Echtermeyer, Thomas Harendza, Svenja Hubrich, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Molecular and Cellular Cardiology|July 21, 2009
MLP: a stress sensor goes nuclearSylvia Gunkel, Jörg Heineke, Denise Hilfiker-Kleiner, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytesKai C Wollert, Beate Fiedler, Stepan Gambaryan, et al.
International Journal of Molecular Sciences|September 22, 2019
FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and FibrosisIneke Böckmann, Jonas Lischka, Beatrice Richter, et al.
Circulation|March 19, 2003
Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophyJörg Heineke, Tibor Kempf, Theresia Kraft, et al.
Cardiovascular Research|July 28, 2004
Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytesJörn Tongers, Beate Fiedler, Danny König, et al.
Circulation Research|January 7, 2006
The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injuryTibor Kempf, Matthias Eden, Jens Strelau, et al.
JCI Insight|May 19, 2017
Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progressionJames T Thackeray, Stefan Pietzsch, Britta Stapel, et al.
European Heart Journal|April 16, 2020
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human heartsLuka Nicin, Wesley Tyler Abplanalp, Hannah Mellentin, et al.
Circulation|January 26, 2011
Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarctionMortimer Korf-Klingebiel, Tibor Kempf, Klaus-Dieter Schlüter, et al.
Cardiovascular Research|June 3, 2011
Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodellingFrank Echtermeyer, Thomas Harendza, Svenja Hubrich, et al.
Pageof 2